GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:25377120
| Citation |
Rostam, MA, Piva, TJ, Rezaei, HB, Kamato, D, Little, PJ, Zheng, W and Osman, N (2015) Peptidyl-prolyl isomerases: Functionality and potential therapeutic targets in cardiovascular disease. Clin. Exp. Pharmacol. Physiol. 42:117-24 |
|---|---|
| Abstract |
Peptidyl-prolyl cis/trans isomerases (PPIases) are a conserved group of enzymes that catalyse the conversion between cis and trans conformations of proline imidic peptide bonds. These enzymes play critical roles in regulatory mechanisms of cellular function and pathophysiology of disease. There are three different classes of PPIases and increasing interest in the development of specific PPIase inhibitors. Cyclosporine A, FK506, rapamycin and juglone are known PPIase inhibitors. Herein, we review recent advances in elucidating the role and regulation of the PPIase family in vascular disease. We focus on peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 (Pin1), an important member of the PPIase family that plays a role in cell cycle progression, gene expression, cell signalling and cell proliferation. In addition, Pin1 may be involved in atherosclerosis. The unique role of Pin1 as a molecular switch that impacts on multiple downstream pathways necessitates the evaluation of a highly specific Pin1 inhibitor to aid in potential therapeutic drug discovery. |
| Links |
PubMed Online version:10.1111/1440-1681.12335 |
| Keywords |
|
| edit table |
Significance
Annotations
| Gene product | Qualifier | GO Term | Evidence Code | with/from | Aspect | Extension | Notes | Status |
|---|---|---|---|---|---|---|---|---|
Notes
See also
References
See Help:References for how to manage references in GONUTS.
